ClinicalTrials.Veeva

Menu

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Stanford University logo

Stanford University

Status

Completed

Conditions

Early Hepatocellular Carcinoma
Stage I Hepatocellular Carcinoma
Cirrhosis
Fibrosis
Stage II Hepatocellular Carcinoma

Treatments

Other: Ultrasound Tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT02774161
NCI-2016-00663 (Registry Identifier)
IRB-36299
GIIMG0007 (Other Identifier)

Details and patient eligibility

About

This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disease has spread.

Full description

PRIMARY OBJECTIVES:

I. To investigate the use of quantitative ultrasound spectroscopy to detect early hepatocellular carcinoma (HCC) as an inexpensive and widely available quantitative (i.e. robust) method to confirm disease in developing countries.

OUTLINE:

Patients undergo B-mode ultrasound imaging of the liver over 15 minutes.

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For Healthy Volunteers

  1. Patients over 18 years of age.
  2. Must have no known medical problems and have had a full medical exam within 6 months of the study. If healthy volunteers have not had a full medical exam within 6 months of the study, one of the ultrasound physicians will conduct the medical exam prior to any study procedures.

For HCC patients

  1. Patients over 18 years of age.
  2. Patient with confirmed diagnosis of HCC, and untreated or Patients with Suspected HCC (Suspected HCC nodules should preferably be smaller than 3 cm and preferably within 6 cm in depth of the transducer head to minimize attenuation) and untreated or Patients at a higher risk of HCC undergoing a screening program by Ultrasound.

Exclusion criteria

For Healthy volunteers

  1. Patients who are not likely to comply with the protocol requirements.

For HCC patients

  1. Patients should not be taking other Investigational Agents.
  2. Concomitant medications for treatment of the target lesion.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

45 participants in 1 patient group

Diagnostic (B-mode ultrasound imaging)
Experimental group
Description:
Patients undergo B-mode ultrasound imaging of the liver over 15 minutes.
Treatment:
Other: Ultrasound Tomography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems